RSV/IAV-IN-3 is a dual inhibitor of respiratory syncytial virus (RSV) and influenza A virus (IAV), with EC50 values of 2.92 µM and 1.90 µM, respectively; it exhibits antiviral activity against H1N1 and H3N2 strains in MDCK cells with EC50 values of 3.25 µM and 1.50 µM, respectively; it significantly inhibits luciferase activity in a dose-dependent manner (EC50 = 3.89 µM); it suppresses IAV infection and RNA-dependent RNA polymerase (RdRp) activity; and it inhibits the replication of both IAV and RSV at the post-entry stage.